Your browser doesn't support javascript.
loading
A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow-up.
Anderson, Larry D; Bladé, Joan; Kyle, Robert A.
Affiliation
  • Anderson LD; Myeloma, Waldenstrom's, and Amyloidosis Program Hematologic Malignancies and Cellular Therapy Program Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas Texas USA.
  • Bladé J; Department of Hematology Amyloidosis and Myeloma Unit Institut d'Investigacions Biomèdiques August Pi i Sunyer Hospital Clínic de Barcelona University de Barcelona Barcelona Spain.
  • Kyle RA; Division of Hematology Mayo Clinic Rochester Minnesota USA.
EJHaem ; 5(1): 235-237, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38406530
ABSTRACT
The presence of a serum immunoglobulin D (IgD) monoclonal protein (M-protein) is seen in < 1% of patients with monoclonal gammopathies and is usually indicative of a malignant plasma cell disorder. Only a few cases of well-documented benign monoclonal gammopathy of undetermined significance (MGUS) of IgD subtype have been reported, and only 2 of those had over 5 years of follow-up at the time they were reported. Herein we describe longer-term follow-up of one of those 2 patients who has subsequently passed away from unrelated causes but never developed multiple myeloma or amyloidosis after 26 years of follow-up. Although IgD MGUS is extremely rare, this case confirms that presence of an IgD M-Protein is not always synonymous with a malignant plasma cell process.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: EJHaem Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: EJHaem Year: 2024 Document type: Article